Posted in Antibodies, Assay Kits, Biology Cells, cDNA, Clia Kits, Culture Cells, Devices, Equipments, Exosomes, Gels, Isotypes, Medium & Serums, Panel, Particles, Reagents, Recombinant Proteins, Ria Kits, RNA
An Innovative Rapid Method for Analysis of 10 Organophosphorus Pesticide Residues in Wheat by HS-SPME-GC-FPD/MSD.
Quick detection of pesticide residues in wheat has become the priority of the top food security. A headspace free headspace solid-phase microextraction (HS-SPME) has been evaluated for fast filtering of organophosphorus pesticide residues (OPP) in wheat with high sensitivity. Individual wheat samples (1.7 g), barbed with 10 opps, placed in a yellow glass bottle 4 ml and heated at 60 ° C for 45 minutes. During this time, the OPP residue was extracted with 50 μm / 30 μm divinylbenzene (DVB) / Carboxen (car) / plasma polydimethylsiloxane (PDMS) fiber (PDMS) mass spectroscopic from the headspace above the sample.
The fiber was then removed and injected into the GC injection port at 250 ° C for desorption of extracted chemicals. Some residues are identified by the GC mass spectrometer detector (GC-MSD) and quantified with Flame GC Photometric Detector (GC-FPD). Seven spiny levels of 10 OPPS on wheat were analyzed. GC response for DVB / car / PDMS 50 μm / 30 μm fibers increased with increased spiking levels, generating significant (2) >> 0.98) linear regression.
The lowest lods of some pesticide standards are evaluated in conditions of validation studies in various levels of 0 (control) up to 100 ng residues of pesticides per g of wheat separated in the GC Polar (DB Agilent) -35UI capillary column). The results of the HS-SPME method compared to the Quephers AOAC 2007.01 method and they showed several advantages over the latter. This includes increased sensitivity, selectivity and simplicity.
Factors that influence the risk of developing disorders of the lower back musculoskeletal (MSDS) in experienced and inexperienced Rod workers.
The level of injury and dropout during Rodwork training seems to reflect the difficulties faced by an adaptable internship with an increase in physical demands binding slab, one of the tasks of work with the highest risk of injury. Because the experience affects the work strategy, and the result of the risk of developing musculoskeletal disorders (MSDS), this study aims to identify differences in work practices related to binding rebar on slabs, potentially relevant to the development of experienced and inexperienced MSDs.
Fourteen men’s Rodworkers are recruited from experienced (> 2 years of post internship experience), or an inexperienced group (experience <6 months). Both of them bind the area with a rebar placed on the ground. The angular flexion / trunk extension is measured.
The Moment of L4 / L5 is estimated from the EMG spinae t9 erector. Experienced workers are found to spend longer in trunk flexion’s posture, with lower L4 / L5 peak moments. Our findings revealed practices related to each group may have different implications on health back.
Application of industrial level participatory ergonomics approach in developing MSD intervention.
Participatory ergonomics projects are traditionally applied in one organization. In this study, a participatory approach was applied throughout the New Zealand meat processing industry, which involved many organizations and geographical areas. The aim is to develop interventions to reduce the risk of musculoskeletal disorders (MSD). This paper considers the value of the industrial level participatory ergonomics approach to achieving this. The main thinking for participatory approaches includes the need for industrial credibility, and to produce MSD interventions that handle industrial level risk factors.
The industry’s main stakeholder groups become major vehicles for formal participation. This study produces an intervention plan that includes a broader work system and industrial practice. This intervention is fought throughout the industry by the main stakeholder groups and has exceeded research life. While this approach helps meet the research objectives, the existence of the main stakeholder group supported by the industry and the mandate for this initiative is important prerequisites for success.
Factors associated with MSD among construction workers.
Evidence regarding the possibility of risk factors associated with musculoskeletal disorders (MSDS) can guide the selection of possible intervention and employment actions to develop ergonomic steps and appropriate safety. The purpose of this study was to explore the factors related to the development of MSD among construction workers. Nordic Musculoskeletal questionnaire is used to measure severity, duration, frequency and prevalence of symptoms of MSDS in nine areas of the anatomy body.

Physical fitness is assessed based on workers’ answers regarding their own physical fitness perceptions. Psychosocial work demands are measured in terms of work control, psychological demands, social support and job dissatisfaction. Some logistic regression is used to identify the factors associated with the upper msds, neck and upper. The results of several logistic regression show that the MSD limbs are distal related to manual handling, repetition of work, psychosocial demands, job dissatisfaction and gender.
MSD neck, shoulders or upper backs related to manual handling, repetition, psychosocial demands, job dissatisfaction, and physical dissatisfaction. This finding shows that reducing the neck, the upper back of the shoulder and the distal limb to the workplace requires the right steps that aim to make the physical environment more suitable with respect to equipment, machinery, tools and furniture, to reduce repetition, use of strength. and manual handling.
Effect of 12 Week Prop Pilates Training Program (PPEP) in body stability and pain for fruit farmers with MSDS.
The purpose of this study was to determine the possible effects of the 12-week Pilates training program (PPEPP) for fruit farmers (wine, tomatoes, apples) with musculoskeletal (MSD) disorders in stability and body pain. 131 Fruit Farmers with MSD were selected and asked to join the 12-Week Pilates Training Program (PPEP) from 2009 to 2012. Subjects (women = 74, male = 57) aged 50 to 65 years participating voluntarily participating.
FGF21 Antibody |
49516-100ul |
SAB |
100ul |
EUR 399.6 |
FGF21 Antibody |
49516-50ul |
SAB |
50ul |
EUR 286.8 |
FGF21 antibody |
70R-14210 |
Fitzgerald |
100 ug |
EUR 386.4 |
Description: Affinity purified Rabbit polyclonal FGF21 antibody |
FGF21 antibody |
70R-6198 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal FGF21 antibody raised against the N terminal of FGF21 |
FGF21 Antibody |
36478-100ul |
SAB |
100ul |
EUR 302.4 |
FGF21 Antibody |
1-CSB-PA290047 |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:1000-1:2000, IHC:1:25-1:100 |
FGF21 Antibody |
1-CSB-PA06404A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
FGF21 Antibody |
1-CSB-PA876229 |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:50-1:200 |
Fgf21 Antibody |
1-CSB-PA008627LA01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA |
FGF21 Antibody |
RQ4485 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
Description: Stimulates glucose uptake in differentiated adipocytes via the induction of glucose transporter SLC2A1/GLUT1 expression (but not SLC2A4/GLUT4 expression). Activity requires the presence of KLB. [UniProt] |
FGF21 Antibody |
R30758 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Fibroblast growth factor 21 is a protein that in humans is encoded by the FGF21 gene, a member of the fibroblast growth factor(FGF) family. Using RT-PCR, the protein was found to express in several types of adipose tissue in mice, including subcutaneous and epididymal fat pads and brown adipose tissue. The level of expression in adipose tissue was comparable to that in liver. FGF21 stimulates glucose uptake in adipocytes but not in other cell types. This effect is additive to the activity of insulin. FGF21 treatment of adipocytes is associated with phosphorylation of FRS2, a protein linking FGF receptors to the Ras/MAP kinase pathway. FGF21 also protects animals from diet-induced obesity when overexpressed in transgenic mice and lowers blood glucose and triglyceride levels when administered to diabetic rodents. Changes in expression due to suckling or nutritional manipulations were associated with changes in circulating free fatty acid and ketone body levels. In differentiated mouse brown adipocytes in culture, Fgf21 treatment increased the expression of thermogenic genes, caused higher total and uncoupled respiration, and enhanced glucose oxidation. |
FGF21 Antibody |
R32531 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Fibroblast growth factor 21 is a protein that in humans is encoded by the FGF21 gene, which is also a member of the fibroblast growth factor (FGF) family. The gene is mapped on 19q13.33. Using RT-PCR, Fgf21 was expressed in several types of adipose tissue in mice, including subcutaneous and epididymal fat pads and brown adipose tissue. The level of expression in adipose tissue was comparable to that in liver. FGF21 stimulates glucose uptake in adipocytes but not in other cell types. This effect is additive to the activity of insulin. FGF21 treatment of adipocytes is associated with phosphorylation of FRS2, a protein linking FGF receptors to the Ras/MAP kinase pathway. FGF21 also protects animals from diet-induced obesity when overexpressed in transgenic mice and lowers blood glucose and triglyceride levels when administered to diabetic rodents. Changes in Fgf21 expression due to suckling or nutritional manipulations were associated with changes in circulating free fatty acid and ketone body levels. In differentiated mouse brown adipocytes in culture, Fgf21 treatment increased the expression of thermogenic genes, caused higher total and uncoupled respiration, and enhanced glucose oxidation. |
FGF21 Antibody |
R33314-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Fibroblast growth factor 21 |
FGF21 Antibody |
E036478 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
FGF21 Antibody |
E19-8947-1 |
EnoGene |
50ug/50ul |
EUR 145 |
Description: Available in various conjugation types. |
FGF21 Antibody |
E19-8947-2 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
FGF21 Antibody |
E306831 |
EnoGene |
100ug/200ul |
EUR 275 |
Description: Available in various conjugation types. |
FGF21 antibody (biotin) |
60R-1444 |
Fitzgerald |
100 ug |
EUR 392.4 |
Description: Rabbit polyclonal FGF21 antibody (biotin) |
FGF21 Conjugated Antibody |
C49516 |
SAB |
100ul |
EUR 476.4 |
FGF21 Conjugated Antibody |
C36478 |
SAB |
100ul |
EUR 476.4 |
FGF21 Polyclonal Antibody |
ABP58547-003ml |
Abbkine |
0.03ml |
EUR 189.6 |
|
Description: A polyclonal antibody for detection of FGF21 from Human. This FGF21 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human FGF21 protein at amino acid sequence of 90-170 |
FGF21 Polyclonal Antibody |
ABP58547-01ml |
Abbkine |
0.1ml |
EUR 346.8 |
|
Description: A polyclonal antibody for detection of FGF21 from Human. This FGF21 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human FGF21 protein at amino acid sequence of 90-170 |
FGF21 Polyclonal Antibody |
ABP58547-02ml |
Abbkine |
0.2ml |
EUR 496.8 |
|
Description: A polyclonal antibody for detection of FGF21 from Human. This FGF21 antibody is for WB, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human FGF21 protein at amino acid sequence of 90-170 |
FGF21 Polyclonal Antibody |
A52640 |
EpiGentek |
-
EUR 684.66
-
Ask for price
-
Ask for price
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
Fgf21 Polyclonal Antibody |
A62586 |
EpiGentek |
-
EUR 684.66
-
EUR 117.70
-
EUR 302.50
-
EUR 423.50
|
- 100 µg
- 20 ul
- 50 ul
- 100 ul
|
FGF21 Polyclonal Antibody |
ES9145-100ul |
ELK Biotech |
100ul |
EUR 334.8 |
Description: A Rabbit Polyclonal antibody against FGF21 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
FGF21 Polyclonal Antibody |
ES9145-50ul |
ELK Biotech |
50ul |
EUR 248.4 |
Description: A Rabbit Polyclonal antibody against FGF21 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA |
FGF21 Polyclonal Antibody |
E11-200199 |
EnoGene |
100ug/100ul |
EUR 225 |
Description: Available in various conjugation types. |
FGF21 Polyclonal Antibody |
E910368 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
FGF21 Antibody, HRP conjugated |
1-CSB-PA06404B0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, HRP conjugated |
1-CSB-PA008627LB01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is HRP conjugated. Tested in the following application: ELISA |
FGF21 Antibody, FITC conjugated |
1-CSB-PA06404C0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, FITC conjugated |
1-CSB-PA008627LC01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is FITC conjugated. Tested in the following application: ELISA |
FGF21 Antibody, Biotin conjugated |
1-CSB-PA06404D0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against FGF21. Recognizes FGF21 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Fgf21 Antibody, Biotin conjugated |
1-CSB-PA008627LD01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Fgf21. Recognizes Fgf21 from Mouse. This antibody is Biotin conjugated. Tested in the following application: ELISA |
FGF21 recombinant monoclonal antibody |
A5710 |
Bimake |
100ul X 3 |
EUR 714 |
|
Description: A recombinant monoclonal antibody from rabbit against human FGF21 for WB ,ELISA |
FGF21 Polyclonal Antibody, HRP Conjugated |
A52639 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, HRP Conjugated |
A62587 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
FGF21 Polyclonal Antibody, FITC Conjugated |
A52638 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, FITC Conjugated |
A62588 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
FGF21 Polyclonal Antibody, Biotin Conjugated |
A52637 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fgf21 Polyclonal Antibody, Biotin Conjugated |
A62589 |
EpiGentek |
-
EUR 684.66
-
EUR 302.50
-
EUR 423.50
|
|
Fibroblast Growth Factor 21 (Fgf21) Antibody |
20-abx319027 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx270292 |
Abbexa |
-
EUR 594.00
-
EUR 693.60
-
EUR 343.20
-
EUR 1062.00
-
EUR 444.00
|
- 100 tests
- 200 tests
- 25 tests
- 500 tests
- 50 tests
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx109786 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx104974 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1095.60
-
EUR 560.40
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx176423 |
Abbexa |
|
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx172402 |
Abbexa |
|
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx172403 |
Abbexa |
|
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx212889 |
Abbexa |
|
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
abx215343-100ug |
Abbexa |
100 ug |
EUR 526.8 |
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx211567 |
Abbexa |
|
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx132281 |
Abbexa |
-
EUR 360.00
-
EUR 844.80
-
EUR 427.20
-
EUR 184.80
-
EUR 292.80
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
abx036536-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx125845 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx129878 |
Abbexa |
-
EUR 526.80
-
EUR 159.60
-
EUR 1479.60
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx130212 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
20-abx130325 |
Abbexa |
-
EUR 393.60
-
EUR 159.60
-
EUR 1045.20
-
EUR 543.60
-
EUR 326.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody |
abx432698-200ul |
Abbexa |
200 ul |
EUR 460.8 |
|
FGF21 Antibody / Fibroblast Growth Factor 21 |
V8452-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Fibroblast growth factor-1 (FGF-1), also designated acidic FGF, and fibroblast growth factor-2 (FGF-2), also designated basic FGF, are members of a family of growth factors that stimulate proliferation of cells of mesenchymal, epithelial and neuroectodermal origin. Additional members of the FGF family include the oncogenes FGF-3 (Int2) and FGF-4 (hst/Kaposi), FGF-5, FGF-6, FGF-7 (KGF), FGF-8 (AIGF), FGF-9 (GAF) and FGF-10-FGF-23. Members of the FGF family share 30-55% amino acid sequence identity and similar gene structure and are capable of transforming cultured cells when overexpressed in transfected cells. Cellular receptors for FGFs are members of a second multigene family including four tyrosine kinases, designated Flg (FGFR-1), Bek (FGFR-L), TKF and FGFR-3. |
FGF21 Antibody / Fibroblast Growth Factor 21 |
V8452-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: Fibroblast growth factor-1 (FGF-1), also designated acidic FGF, and fibroblast growth factor-2 (FGF-2), also designated basic FGF, are members of a family of growth factors that stimulate proliferation of cells of mesenchymal, epithelial and neuroectodermal origin. Additional members of the FGF family include the oncogenes FGF-3 (Int2) and FGF-4 (hst/Kaposi), FGF-5, FGF-6, FGF-7 (KGF), FGF-8 (AIGF), FGF-9 (GAF) and FGF-10-FGF-23. Members of the FGF family share 30-55% amino acid sequence identity and similar gene structure and are capable of transforming cultured cells when overexpressed in transfected cells. Cellular receptors for FGFs are members of a second multigene family including four tyrosine kinases, designated Flg (FGFR-1), Bek (FGFR-L), TKF and FGFR-3. |
FGF21 Antibody / Fibroblast Growth Factor 21 |
V8452SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: Fibroblast growth factor-1 (FGF-1), also designated acidic FGF, and fibroblast growth factor-2 (FGF-2), also designated basic FGF, are members of a family of growth factors that stimulate proliferation of cells of mesenchymal, epithelial and neuroectodermal origin. Additional members of the FGF family include the oncogenes FGF-3 (Int2) and FGF-4 (hst/Kaposi), FGF-5, FGF-6, FGF-7 (KGF), FGF-8 (AIGF), FGF-9 (GAF) and FGF-10-FGF-23. Members of the FGF family share 30-55% amino acid sequence identity and similar gene structure and are capable of transforming cultured cells when overexpressed in transfected cells. Cellular receptors for FGFs are members of a second multigene family including four tyrosine kinases, designated Flg (FGFR-1), Bek (FGFR-L), TKF and FGFR-3. |
Fibroblast Growth Factor 21 (Fgf21) Antibody (HRP) |
20-abx319028 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody (HRP) |
20-abx108255 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (Fgf21) Antibody (FITC) |
20-abx319029 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody (FITC) |
20-abx106836 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody Pair |
abx117307-1pair5x96wellplates |
Abbexa |
1 pair (5x96 well plates) |
EUR 1212 |
|
Fibroblast Growth Factor 21 (Fgf21) Antibody (Biotin) |
20-abx319030 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Fibroblast Growth Factor 21 (FGF21) Antibody (Biotin) |
20-abx105417 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Monoclonal FGF21 Antibody (monoclonal) (M04), Clone: 3A6 |
AMM04538G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human FGF21 (monoclonal) (M04). The antibodies are raised in mouse and are from clone 3A6. This antibody is applicable in WB |
Monoclonal FGF21 Antibody (monoclonal) (M01), Clone: 2F11 |
AMM04537G |
Leading Biology |
0.1mg |
EUR 580.8 |
Description: A Monoclonal antibody against Human FGF21 (monoclonal) (M01). The antibodies are raised in mouse and are from clone 2F11. This antibody is applicable in WB and IHC, E |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31603-100ul |
Biomatik Corporation |
100ul |
EUR 282.2 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31603-200ul |
Biomatik Corporation |
200ul |
EUR 352.8 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31604-100ul |
Biomatik Corporation |
100ul |
EUR 255.4 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31604-200ul |
Biomatik Corporation |
200ul |
EUR 319.2 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31605-100ul |
Biomatik Corporation |
100ul |
EUR 248.6 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU31605-200ul |
Biomatik Corporation |
200ul |
EUR 310.8 |
Fibroblast Growth Factor 21 (FGF21) Monoclonal Antibody |
CAU29872-100ul |
Biomatik Corporation |
100ul |
EUR 194.9 |
Fibroblast Growth Factor 21 (FGF21) Monoclonal Antibody |
CAU29872-200ul |
Biomatik Corporation |
200ul |
EUR 243.6 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23743-100ul |
Biomatik Corporation |
100ul |
EUR 255.4 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23743-200ul |
Biomatik Corporation |
200ul |
EUR 319.2 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23744-100ul |
Biomatik Corporation |
100ul |
EUR 241.9 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23744-200ul |
Biomatik Corporation |
200ul |
EUR 302.4 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23745-100ul |
Biomatik Corporation |
100ul |
EUR 179 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody |
CAU23745-200ul |
Biomatik Corporation |
200ul |
EUR 219 |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat) |
4-PAC918Ra01 |
Cloud-Clone |
-
EUR 310.80
-
EUR 3249.60
-
EUR 804.00
-
EUR 393.60
-
EUR 262.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21) |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human) |
4-PAC918Hu01 |
Cloud-Clone |
-
EUR 246.00
-
EUR 2220.00
-
EUR 570.00
-
EUR 300.00
-
EUR 235.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21) |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse) |
4-PAC918Mu02 |
Cloud-Clone |
-
EUR 301.20
-
EUR 3091.20
-
EUR 768.00
-
EUR 379.20
-
EUR 258.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21) |
Fibroblast Growth Factor 21 (FGF21) Monoclonal Antibody (Human) |
4-MAC918Hu22 |
Cloud-Clone |
-
EUR 265.20
-
EUR 2536.80
-
EUR 642.00
-
EUR 328.80
-
EUR 243.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Mouse monoclonal antibody against Human Fibroblast Growth Factor 21 (FGF21) |
Rat FGF21 EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
EZ1595 |
BosterBio |
5 plates/kit |
EUR 370.8 |
Description: For the development of sandwich ELISA kit to measure rat FGF21 in cell culture supernates, serum and plasma (heparin, EDTA). |
Human FGF21 EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
EZ0994 |
BosterBio |
5 plates/kit |
EUR 321.6 |
Description: For the development of sandwich ELISA kit to measure human FGF21 in cell culture supernates, cell lysates, tissue homogenates, serum and plasma (heparin, EDTA). |
Mouse FGF21 EZ-Set™ ELISA Kit (DIY Antibody Pairs) |
EZ1379 |
BosterBio |
5 plates/kit |
EUR 370.8 |
Description: For the development of sandwich ELISA kit to measure mouse FGF21 in cell culture supernates, cell lysates, serum and plasma (heparin, EDTA). |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat), PE |
4-PAC918Ra01-PE |
Cloud-Clone |
-
EUR 373.20
-
EUR 3427.20
-
EUR 964.80
-
EUR 471.60
-
EUR 242.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with PE. |
FGF21 |
cyt-474 |
ProSpec Tany |
5µg |
EUR 60 |
Description: Recombinant Human Fibroblast Growth Factor-21 |
FGF21 |
E8ET1704-04 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
FGF21 |
E8EM170405 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat), APC |
4-PAC918Ra01-APC |
Cloud-Clone |
-
EUR 436.80
-
EUR 4254.00
-
EUR 1176.00
-
EUR 560.40
-
EUR 272.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with APC. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat), Cy3 |
4-PAC918Ra01-Cy3 |
Cloud-Clone |
-
EUR 532.80
-
EUR 5622.00
-
EUR 1518.00
-
EUR 697.20
-
EUR 313.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with Cy3. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat), HRP |
4-PAC918Ra01-HRP |
Cloud-Clone |
-
EUR 398.40
-
EUR 3706.80
-
EUR 1039.20
-
EUR 505.20
-
EUR 255.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with HRP. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), PE |
4-PAC918Hu01-PE |
Cloud-Clone |
-
EUR 295.20
-
EUR 2304.00
-
EUR 684.00
-
EUR 360.00
-
EUR 208.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with PE. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Mouse), PE |
4-PAC918Mu02-PE |
Cloud-Clone |
-
EUR 361.20
-
EUR 3254.40
-
EUR 921.60
-
EUR 454.80
-
EUR 236.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Mouse Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with PE. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Rat), FITC |
4-PAC918Ra01-FITC |
Cloud-Clone |
-
EUR 373.20
-
EUR 3427.20
-
EUR 964.80
-
EUR 471.60
-
EUR 242.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Rat Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with FITC. |
Fibroblast Growth Factor 21 (FGF21) Monoclonal Antibody (Human), PE |
4-MAC918Hu22-PE |
Cloud-Clone |
-
EUR 319.20
-
EUR 2649.60
-
EUR 770.40
-
EUR 393.60
-
EUR 218.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Mouse monoclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with PE. |
Fibroblast Growth Factor 21 (FGF21) Polyclonal Antibody (Human), APC |
4-PAC918Hu01-APC |
Cloud-Clone |
-
EUR 338.40
-
EUR 2850.00
-
EUR 824.40
-
EUR 420.00
-
EUR 230.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Fibroblast Growth Factor 21 (FGF21). This antibody is labeled with APC. |
As a result, it was found that medial lateral and anterior-posterior body increased significantly in male and female fruit farmers. It was found that the pain index (VAS) after the 12-week Pilates Prop Program (PPEP) showed a significant decrease.